Principal Scientist | Molecular Biology

PopVax is an Indian full‑stack biotech building first‑in‑class and best‑in‑class vaccines and cancer immunotherapies using machine learning‑driven design and relentless empiricism. We design, develop, and manufacture our own RNA medicines end‑to‑end because we believe great pharmaceutical science can only flourish in tight feedback loops that iterate rapidly. PopVax’s experimental work and clinical dose production is based at the RNA Foundry, our integrated R&D and GMP‑capable clinical dose production facility in Hyderabad.
PopVax's north star is our goal of developing novel vaccines and therapeutics over the next decade with the cumulative ability to save 1 million lives each year – the Million Lives Mission. To that end, we are developing first‑in‑class vaccines against Hepatitis C Virus, Strep A, and adult pulmonary TB, broadly‑protective best‑in‑class vaccines against COVID‑19, influenza, and HPV, and precision immunotherapies against hard‑to‑treat solid tumours such as liver ca...